ArticleSignal transduction and targeted therapy2022

STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway.

Ran Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.